SlideShare a Scribd company logo
1 of 29
Infective Endocarditis
PRATIK KUMAR
080201186
Definition
Infection of the endocardial surface of heart characterized by
 - Colonization or invasion of the heart valves (native or
prosthetic) or the mural endocardium by a microbe,
 - leading to formation of bulky, friable vegetation composed
of thrombotic debris and organisms
 - often associated with destruction of underlying cardiac
tissue.
Sites involved
• Heart valves
• Ventricular septum defects
• Mural endocardium
• Intracardiac devices




• INFECTIVE ENDARTERITIS – analogus
Classification
 ACUTE ENDOCARDITIS                SUBACUTE ENDOCARDITIS

• Destructive and tumultuous       • Organisms of low virulence
  infection, frequently of a         causing infection in a
  previously normal heart valve,     previously abnormal heart,
  with a highly virulent             particularly on deformed
  organism                           valves.
• Hematogenoulsy seeds             • Disease appear insidiously and
                                     pursue a protracted course of
• If untreated, leads to death       weeks to month
  within weeks
                                   • Recover after appropriate
                                     antibiotic treatment
Predisposing factors
 CARDIAC AND VASCULAR ABNORMALITIES    HOST FACTORS

• RHD                                 • Neutropenia
• Myxomatous mitral valve             • Immunodeficiency
• Degenerative calcific valvular      • Malignancy
  stenosis                            • Therapeutic immunosuppression
• Bicuspid aortic valves              • Diabetes mellitus
• Prosthetic valves                   • Alcohol
                                      • IV drug abuse
Microbiology
• Staphylococcus aureus (35%) : Either healthy or deformed valves, IV drug
  abusers (polymicrobial), devices
• Streptococcus viridans (32%) : Native but previously damaged/abnormal
  valves
• Enterococci (8 %)
• CoNS - S. epidermidis (4%): Prosthetic valve endocarditis, devices
• G –ve bacilli of HACEK group (4%)
• Yeast and Fungi(1%)
• Culture negative endocarditis (5 %)
Pathogenesis
Portal of entry:
◦ Dental / Surgical Procedures
◦ Contamination by IV drug use
◦ Obvious infections (RS/Skin)
◦ Occult source from gut, oral cavity
◦ Trivial injuries.
◦ Intravascular catheter infection
◦ Nosocomial wounds
◦ Chronic invasive procedures
Endothelial Injury


    Uninfected Platelet-Fibrin thrombus (NBTE)

        Transient bacteremia and attachment at
        NBTE

            Proliferation and pro-coagulant state


                Infected, friable, bulky vegetation
Morphology
• Friable, bulky vegetation containing fibrin, inflammatory cells, and microbes
• Aortic and mitral valves involved most commonly.
• Right side valve involvement in iv drug users.
Clinical features
 Symptoms                        Constitutional symptoms


 - Damage    to intracardiac     --- Cytokine release ?
structures
  - Embolization of vegetation
fragments
 - Hematogenous infection
 - Immune complex
Sub-acute Endocarditis

• Persistent fever
• Constitutional symptoms
• New signs of valve
  dysfunction
• Heart failure



• Embolic Stroke
• Peripheral arterial
  embolism


• Other features
Modified Dukes Criteria for diagnosis
of Infective Endocarditis
    Definitive Endocarditis if,
    - Two major or,
    - One major and three minor or,
    - five minor


    Possible Endocarditis if,
    - One major and one minor or,
    - Three minor
Major Criteria
Positive blood culture
◦Typical organism from two cultures
◦Persistent positive blood cultures taken > 12 hours apart
◦Three or more positive cultures taken over more than 1
 hour.
Endocardial involvement
◦Positive echocardiographic findings of vegetations
◦New valvular regurgitation
Minor Criteria
• Predisposition: Predisposing valvular or cardiac abnormality
• Intravenous drug misuse
• Pyrexia ≥38°C (≥100.4°F)
• Embolic phenomenon
• Vasculitic/ immunologic phenomenon
• Blood cultures suggestive: -organism grown but not achieving
  major criteria
• Suggestive echocardiographic findings
INVESTIGATIO
NS
AVINASH BAJJURI
.
Microbiology
 Blood cultures:
Key diagnostic investigation in infective endocarditis.
Isolation of microorganism from culture is important for
 diagnosis and also for treatment.
At least 3 sets of samples should be taken from different
 venepuncture sites over 24 hours.
Serology
 Can be sent when the diagnosis is suspected and the
 cultures are negative.
They aid in cases where the organisms will not grow in
 blood cultures(Coxiella,Legionella,Bartonella)
ECG
 To detect complications like MI,conduction
abnormalities.
CHEST X RAY
.
Echocardiography
It can identify the presence and size of
 vegetations,detect intracardiac complications and
 assess cardiac function.
Transthoracic echocardiography is noninvasive and has
 high specificity for visualising vegetations.
Transoesophageal echocardiography is more sensitive
 than TTE.It can detect small vegetations,prosthetic
 endocarditis and intra cardiac complications.
.
Complete blood counts
  may show anamia and increased WBC counts.
Urea and Creatinine:
  may be elevated due to glomerulonephritis
Liver biochemistry:
   Serum alkaline phosphatase may be increased
Inflammatory markers
  CRP,ESR are increased in infection .CRP also helps in
 monotoring response to therapy.
Urine
   proteinuria and hematuria occur frequently.
TREATMENT
Antimicrobial Therapy
 Therapy requires identification of specific pathogen
 and its susceptibility to antimicrobials.
 Empirical therapy should be started as soon as
 possible targeting most likely pathogens.
 Bactericidal drugs should be used.
Resolution of fever occurs in 5 to 7 days.if fever
persists patient should be evaluated for complications
like paravalvular abscess and extracardiac abscess.
 Serologic abnormalities resolve slowly and do not
reflect response to treatment.
Antibotic regimen for infective endocarditis
 Streptococci
  Benzyl penicillin (1.2g 4 hourly) 4-6 weeks
  Gentamicin (1mg/kg 8-12 hourly) 4-6 weeks
Enterococci
o Ampicillin sensitive
   Ampicillin (2 g 4 hourly) 4-6 weeks, and
   Gentamicin (1mg/kg 8-12 hourly)
o Ampicillin resistant
   Vancomycin(1g 12hourly) 4-6 weeks, and
   Gentamicin (1mg/kg 8-12 hourly)
Staphycocci
oPenicillin sensitive
   Benzyl penicillin I.V(1.2 g 4 hourly)
oPenicillin resistant but methicillin sensitive
   Flucloxacillin I.V (2g 4 hourly )
oBoth penicillin and methicillin resistant
   Vancomycin I.V (1g 12 hourly) and
   Gentamicin
.
Surgery
 Indications
 patients with direct extension of infection to
 myocardial structuires.
Prosthetic valve dysfunction.
Congestive heart failure.
Badly damaged valves.
IE caused by fungi or gram-ve or resistant organisms.
Large vegetations on echocardiography
Recurrent embolic attacks.
Prophylaxis
  High risk category
 prosthetic cardiac valves
Previous bacterial endocarditis,even in absense of
 heart disease.
Complex cyanotic congenital heart disease(TGA,TOF)
 Surgically constructed systemic pulmonary shunts.
Moderate risk category
Rheumatic and other valvular dysfunction
Congenital cardiac malformations
Hypertrophic cardiomyopathy
Mitral valve prolapse with valvular regurgitation
Regimen for IE prophylaxis
 Standard oral regime
 Amoxicillin 2 g 1hr before procedure
 Inability to take oral medication
  Ampicillin 2g IV or IM 1hr before procedure
Penicillin allergy
  Clindamycin 600 mg
  Clarithromycin 500 mg
  Cephalexin 2 g.
Thank you.

More Related Content

What's hot

What's hot (20)

Pericarditis
PericarditisPericarditis
Pericarditis
 
Myocarditis
MyocarditisMyocarditis
Myocarditis
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Atrial Fibrillation by Dr. Aryan
Atrial Fibrillation by Dr. AryanAtrial Fibrillation by Dr. Aryan
Atrial Fibrillation by Dr. Aryan
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
INTERNAL MEDICINE - Secondary Hypertension
INTERNAL MEDICINE - Secondary HypertensionINTERNAL MEDICINE - Secondary Hypertension
INTERNAL MEDICINE - Secondary Hypertension
 
Acute Myocardial Infarction
Acute Myocardial InfarctionAcute Myocardial Infarction
Acute Myocardial Infarction
 
Acute coronary syndromes
Acute coronary syndromesAcute coronary syndromes
Acute coronary syndromes
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
 
Acute viral myocarditis
Acute viral  myocarditisAcute viral  myocarditis
Acute viral myocarditis
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Myocarditis
MyocarditisMyocarditis
Myocarditis
 
Infective endocarditis[1] (2)
Infective endocarditis[1] (2)Infective endocarditis[1] (2)
Infective endocarditis[1] (2)
 
Ischaemic heart diseases
Ischaemic heart diseasesIschaemic heart diseases
Ischaemic heart diseases
 
Infective Endocarditis and It's Surgical Management
Infective Endocarditis and It's Surgical ManagementInfective Endocarditis and It's Surgical Management
Infective Endocarditis and It's Surgical Management
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Endocarditis
EndocarditisEndocarditis
Endocarditis
 

Viewers also liked

Viewers also liked (20)

Infective endocarditis guidelines 2015
Infective endocarditis guidelines 2015Infective endocarditis guidelines 2015
Infective endocarditis guidelines 2015
 
Endocarditis 2015
Endocarditis  2015Endocarditis  2015
Endocarditis 2015
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
heart failure in children 2015
heart failure in children 2015heart failure in children 2015
heart failure in children 2015
 
Seminar of Endocarditis by Sudeep,(Pharm.D.)
Seminar of  Endocarditis by Sudeep,(Pharm.D.)Seminar of  Endocarditis by Sudeep,(Pharm.D.)
Seminar of Endocarditis by Sudeep,(Pharm.D.)
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Nephrotic syndrome in children
Nephrotic syndrome in childrenNephrotic syndrome in children
Nephrotic syndrome in children
 
NEPHROTIC SYNDROME
NEPHROTIC SYNDROMENEPHROTIC SYNDROME
NEPHROTIC SYNDROME
 
Acute pericarditis
Acute pericarditisAcute pericarditis
Acute pericarditis
 
TRANS ESOPHAGEAL ECHOCARDIOGRAPHY
TRANS ESOPHAGEAL ECHOCARDIOGRAPHYTRANS ESOPHAGEAL ECHOCARDIOGRAPHY
TRANS ESOPHAGEAL ECHOCARDIOGRAPHY
 
ECG: Atrial Flutter
ECG: Atrial FlutterECG: Atrial Flutter
ECG: Atrial Flutter
 
Vsd
VsdVsd
Vsd
 
Glycated haemoglobin ppt by Basalingappa BG
Glycated haemoglobin ppt by Basalingappa BGGlycated haemoglobin ppt by Basalingappa BG
Glycated haemoglobin ppt by Basalingappa BG
 
Rheumatic Heart Disease
Rheumatic Heart DiseaseRheumatic Heart Disease
Rheumatic Heart Disease
 
Diagnosis of diabetes mellitus
Diagnosis of diabetes mellitus  Diagnosis of diabetes mellitus
Diagnosis of diabetes mellitus
 
Nursing care of client with Coronary artery disease part 2 of 2
Nursing care of client with Coronary artery disease part 2 of 2Nursing care of client with Coronary artery disease part 2 of 2
Nursing care of client with Coronary artery disease part 2 of 2
 
Cyanosis
Cyanosis Cyanosis
Cyanosis
 
Ventricular septal defect (vsd)
Ventricular septal defect (vsd)Ventricular septal defect (vsd)
Ventricular septal defect (vsd)
 

Similar to Infective endocarditis

Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisPratik Kumar
 
INFECTIVE ENDOCARDITITS
INFECTIVE ENDOCARDITITSINFECTIVE ENDOCARDITITS
INFECTIVE ENDOCARDITITSAamir Hela
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisFarhan Ali
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisjohnedward869
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditismishka12345
 
INFECTIVE ENDOCARDITIS FMCJ.pptx
INFECTIVE ENDOCARDITIS FMCJ.pptxINFECTIVE ENDOCARDITIS FMCJ.pptx
INFECTIVE ENDOCARDITIS FMCJ.pptxOyovwiPedro1
 
Infective endocarditis 2020
Infective endocarditis 2020Infective endocarditis 2020
Infective endocarditis 2020Nitin Das
 
Infective endocarditis – an update
Infective endocarditis – an update Infective endocarditis – an update
Infective endocarditis – an update Harshitha S
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisKalpana Gogoi
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisEngidaw Ambelu
 
Infective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali Ebrahim
Infective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali EbrahimInfective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali Ebrahim
Infective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali EbrahimBasil Tumaini
 
Infective endocarditis-CARDIO PPT.pptx
Infective endocarditis-CARDIO PPT.pptxInfective endocarditis-CARDIO PPT.pptx
Infective endocarditis-CARDIO PPT.pptxAnirudh Maslekar
 
Endocarditis and its management
Endocarditis and its managementEndocarditis and its management
Endocarditis and its managementShweta Sharma
 
4. Infective endocarditis.pptx
4. Infective endocarditis.pptx4. Infective endocarditis.pptx
4. Infective endocarditis.pptxTsionEnbelew
 
Endocarditis april 2018
Endocarditis  april 2018Endocarditis  april 2018
Endocarditis april 2018Meher Rizvi
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective EndocarditisDiya Saleh
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisdrfarhatbashir
 

Similar to Infective endocarditis (20)

Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
INFECTIVE ENDOCARDITITS
INFECTIVE ENDOCARDITITSINFECTIVE ENDOCARDITITS
INFECTIVE ENDOCARDITITS
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
INFECTIVE ENDOCARDITIS FMCJ.pptx
INFECTIVE ENDOCARDITIS FMCJ.pptxINFECTIVE ENDOCARDITIS FMCJ.pptx
INFECTIVE ENDOCARDITIS FMCJ.pptx
 
Infective endocarditis 2020
Infective endocarditis 2020Infective endocarditis 2020
Infective endocarditis 2020
 
Infective endocarditis – an update
Infective endocarditis – an update Infective endocarditis – an update
Infective endocarditis – an update
 
Infective endocarditis
Infective endocarditis Infective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali Ebrahim
Infective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali EbrahimInfective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali Ebrahim
Infective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali Ebrahim
 
Infective endocarditis-CARDIO PPT.pptx
Infective endocarditis-CARDIO PPT.pptxInfective endocarditis-CARDIO PPT.pptx
Infective endocarditis-CARDIO PPT.pptx
 
Endocarditis and its management
Endocarditis and its managementEndocarditis and its management
Endocarditis and its management
 
4. Infective endocarditis.pptx
4. Infective endocarditis.pptx4. Infective endocarditis.pptx
4. Infective endocarditis.pptx
 
Endocarditis april 2018
Endocarditis  april 2018Endocarditis  april 2018
Endocarditis april 2018
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
2.3. IE.ppt
2.3. IE.ppt2.3. IE.ppt
2.3. IE.ppt
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 

More from Pratik Kumar

More from Pratik Kumar (20)

Tuberculin n scalp vein needle
Tuberculin n scalp vein needleTuberculin n scalp vein needle
Tuberculin n scalp vein needle
 
Treatment protocol of snake bite
Treatment protocol of snake biteTreatment protocol of snake bite
Treatment protocol of snake bite
 
Treatment of pda
Treatment of pdaTreatment of pda
Treatment of pda
 
Paeds
PaedsPaeds
Paeds
 
Paediatrics instruments
Paediatrics instrumentsPaediatrics instruments
Paediatrics instruments
 
Paediatric procedures part 2
Paediatric procedures part 2Paediatric procedures part 2
Paediatric procedures part 2
 
Paediatric procedures part 1
Paediatric procedures part 1Paediatric procedures part 1
Paediatric procedures part 1
 
Lumbar puncture and bone marrow aspiration
Lumbar puncture and bone marrow aspirationLumbar puncture and bone marrow aspiration
Lumbar puncture and bone marrow aspiration
 
Leprosy
LeprosyLeprosy
Leprosy
 
Laryngoscope
LaryngoscopeLaryngoscope
Laryngoscope
 
Laproscopy instruments
Laproscopy instrumentsLaproscopy instruments
Laproscopy instruments
 
Instruments ophthalmology
Instruments   ophthalmologyInstruments   ophthalmology
Instruments ophthalmology
 
Histoy
HistoyHistoy
Histoy
 
Hemoptysis
HemoptysisHemoptysis
Hemoptysis
 
Gc2 ascitis
Gc2  ascitisGc2  ascitis
Gc2 ascitis
 
Gc1 chd
Gc1  chdGc1  chd
Gc1 chd
 
Gc hydrocephalus
Gc  hydrocephalusGc  hydrocephalus
Gc hydrocephalus
 
Endotracheal tubes
Endotracheal tubesEndotracheal tubes
Endotracheal tubes
 
Ecg !
Ecg !Ecg !
Ecg !
 
Chest x rays
Chest x raysChest x rays
Chest x rays
 

Infective endocarditis

  • 2. Definition Infection of the endocardial surface of heart characterized by - Colonization or invasion of the heart valves (native or prosthetic) or the mural endocardium by a microbe, - leading to formation of bulky, friable vegetation composed of thrombotic debris and organisms - often associated with destruction of underlying cardiac tissue.
  • 3. Sites involved • Heart valves • Ventricular septum defects • Mural endocardium • Intracardiac devices • INFECTIVE ENDARTERITIS – analogus
  • 4. Classification ACUTE ENDOCARDITIS SUBACUTE ENDOCARDITIS • Destructive and tumultuous • Organisms of low virulence infection, frequently of a causing infection in a previously normal heart valve, previously abnormal heart, with a highly virulent particularly on deformed organism valves. • Hematogenoulsy seeds • Disease appear insidiously and pursue a protracted course of • If untreated, leads to death weeks to month within weeks • Recover after appropriate antibiotic treatment
  • 5. Predisposing factors CARDIAC AND VASCULAR ABNORMALITIES HOST FACTORS • RHD • Neutropenia • Myxomatous mitral valve • Immunodeficiency • Degenerative calcific valvular • Malignancy stenosis • Therapeutic immunosuppression • Bicuspid aortic valves • Diabetes mellitus • Prosthetic valves • Alcohol • IV drug abuse
  • 6. Microbiology • Staphylococcus aureus (35%) : Either healthy or deformed valves, IV drug abusers (polymicrobial), devices • Streptococcus viridans (32%) : Native but previously damaged/abnormal valves • Enterococci (8 %) • CoNS - S. epidermidis (4%): Prosthetic valve endocarditis, devices • G –ve bacilli of HACEK group (4%) • Yeast and Fungi(1%) • Culture negative endocarditis (5 %)
  • 7. Pathogenesis Portal of entry: ◦ Dental / Surgical Procedures ◦ Contamination by IV drug use ◦ Obvious infections (RS/Skin) ◦ Occult source from gut, oral cavity ◦ Trivial injuries. ◦ Intravascular catheter infection ◦ Nosocomial wounds ◦ Chronic invasive procedures
  • 8. Endothelial Injury Uninfected Platelet-Fibrin thrombus (NBTE) Transient bacteremia and attachment at NBTE Proliferation and pro-coagulant state Infected, friable, bulky vegetation
  • 9. Morphology • Friable, bulky vegetation containing fibrin, inflammatory cells, and microbes • Aortic and mitral valves involved most commonly. • Right side valve involvement in iv drug users.
  • 10. Clinical features Symptoms Constitutional symptoms - Damage to intracardiac --- Cytokine release ? structures - Embolization of vegetation fragments - Hematogenous infection - Immune complex
  • 11. Sub-acute Endocarditis • Persistent fever • Constitutional symptoms • New signs of valve dysfunction • Heart failure • Embolic Stroke • Peripheral arterial embolism • Other features
  • 12.
  • 13. Modified Dukes Criteria for diagnosis of Infective Endocarditis Definitive Endocarditis if, - Two major or, - One major and three minor or, - five minor Possible Endocarditis if, - One major and one minor or, - Three minor
  • 14. Major Criteria Positive blood culture ◦Typical organism from two cultures ◦Persistent positive blood cultures taken > 12 hours apart ◦Three or more positive cultures taken over more than 1 hour. Endocardial involvement ◦Positive echocardiographic findings of vegetations ◦New valvular regurgitation
  • 15. Minor Criteria • Predisposition: Predisposing valvular or cardiac abnormality • Intravenous drug misuse • Pyrexia ≥38°C (≥100.4°F) • Embolic phenomenon • Vasculitic/ immunologic phenomenon • Blood cultures suggestive: -organism grown but not achieving major criteria • Suggestive echocardiographic findings
  • 17. . Microbiology  Blood cultures: Key diagnostic investigation in infective endocarditis. Isolation of microorganism from culture is important for diagnosis and also for treatment. At least 3 sets of samples should be taken from different venepuncture sites over 24 hours.
  • 18. Serology  Can be sent when the diagnosis is suspected and the cultures are negative. They aid in cases where the organisms will not grow in blood cultures(Coxiella,Legionella,Bartonella) ECG To detect complications like MI,conduction abnormalities. CHEST X RAY
  • 19. . Echocardiography It can identify the presence and size of vegetations,detect intracardiac complications and assess cardiac function. Transthoracic echocardiography is noninvasive and has high specificity for visualising vegetations. Transoesophageal echocardiography is more sensitive than TTE.It can detect small vegetations,prosthetic endocarditis and intra cardiac complications.
  • 20. . Complete blood counts may show anamia and increased WBC counts. Urea and Creatinine: may be elevated due to glomerulonephritis Liver biochemistry: Serum alkaline phosphatase may be increased Inflammatory markers CRP,ESR are increased in infection .CRP also helps in monotoring response to therapy. Urine proteinuria and hematuria occur frequently.
  • 21. TREATMENT Antimicrobial Therapy Therapy requires identification of specific pathogen and its susceptibility to antimicrobials. Empirical therapy should be started as soon as possible targeting most likely pathogens. Bactericidal drugs should be used.
  • 22. Resolution of fever occurs in 5 to 7 days.if fever persists patient should be evaluated for complications like paravalvular abscess and extracardiac abscess. Serologic abnormalities resolve slowly and do not reflect response to treatment.
  • 23. Antibotic regimen for infective endocarditis  Streptococci Benzyl penicillin (1.2g 4 hourly) 4-6 weeks Gentamicin (1mg/kg 8-12 hourly) 4-6 weeks Enterococci o Ampicillin sensitive Ampicillin (2 g 4 hourly) 4-6 weeks, and Gentamicin (1mg/kg 8-12 hourly) o Ampicillin resistant Vancomycin(1g 12hourly) 4-6 weeks, and Gentamicin (1mg/kg 8-12 hourly)
  • 24. Staphycocci oPenicillin sensitive Benzyl penicillin I.V(1.2 g 4 hourly) oPenicillin resistant but methicillin sensitive Flucloxacillin I.V (2g 4 hourly ) oBoth penicillin and methicillin resistant Vancomycin I.V (1g 12 hourly) and Gentamicin
  • 25. . Surgery Indications  patients with direct extension of infection to myocardial structuires. Prosthetic valve dysfunction. Congestive heart failure. Badly damaged valves. IE caused by fungi or gram-ve or resistant organisms. Large vegetations on echocardiography Recurrent embolic attacks.
  • 26. Prophylaxis High risk category  prosthetic cardiac valves Previous bacterial endocarditis,even in absense of heart disease. Complex cyanotic congenital heart disease(TGA,TOF)  Surgically constructed systemic pulmonary shunts.
  • 27. Moderate risk category Rheumatic and other valvular dysfunction Congenital cardiac malformations Hypertrophic cardiomyopathy Mitral valve prolapse with valvular regurgitation
  • 28. Regimen for IE prophylaxis Standard oral regime Amoxicillin 2 g 1hr before procedure Inability to take oral medication Ampicillin 2g IV or IM 1hr before procedure Penicillin allergy Clindamycin 600 mg Clarithromycin 500 mg Cephalexin 2 g.